Lyophilized Powder Hot Sale 99% Purity Freeze-dried Powder SS-31
8 Inquiries
796043-06-6
Pharmaceutical Grade
99.6%
ningbo
peijia
5mg , 10mg , 15mg , 20mg or 30mg per vial,10vials/kit
2026-09-13
peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
NA
CAS No.:796043-06-6
Molecular Formula:C21H30N2O6S
Molecular Weight:438.54
Categories:
Characteristics-
Density:
1.373±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
Boiling Point:605.408±63.00 °C(Press: 760.00 Torr)(predicted)
PKA:14.773±0.10(predicted)
Research-
Class:
Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)
Status:FDA-approved (Forzinity) — Accelerated Approval 2025
Mechanism:A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.
Activity note:SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.
Source:Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI
Clinical Development:FDA:Forzinity (approved 2025-09-19)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
FDA: Forzinity (NDA 215244) — Accelerated Approval 2025; Genetics in Medicine: TAZPOWER Phase 2/3 results (Thompson et al. 2020); Drugs: Elamipretide First Approval (Springer 2025)
Disclaimer:Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Hangzhou Peijia E-commerce Co., LTD
-
Year of Establishment:
2026
-
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted
United States
Retatrutide 10mg Retatrutide 10mg
10 MT May 16, 2026
United States
Peptide
1 MT Feb 13, 2026
United States
Peptide
100 Jan 28, 2026
Ireland
retatrutide 10mg
10 Mar 27, 2026
Canada
Peptide
10 G Mar 1, 2026
Canada
Peptide
1 MT Feb 24, 2026
United States
Retatrutide 10 mg
10 MG Mar 4, 2026
Hongkong, China
Peptide
10000 MT Jan 6, 2026 Post an enquiry for this product